Targeted genomic knock-ins are a valuable tool to probe gene function. However, knock-in methods involving homology directed repair (HDR) can be laborious. Here, we adapt the mammalian CRISPaint [clustered regularly interspaced short palindromic repeat (CRISPR)-assisted insertion tagging] homology-independent knock-in method for Drosophila melanogaster, which uses CRISPR/ Cas9 and nonhomologous end joining to insert “universal” donor plasmids into the genome. Using this method in cultured S2R+ cells, we efficiently tagged four endogenous proteins with the bright fluorescent protein mNeonGreen, thereby demonstrating that an existing collection of CRISPaint universal donor plasmids is compatible with insect cells. In addition, we inserted the transgenesis marker 3xP3-red fluorescent protein into seven genes in the fly germ line, producing heritable loss-of-function alleles that were isolated by simple fluorescence screening. Unlike in cultured cells, insertions/deletions always occurred at the genomic insertion site, which prevents predictably matching the insert coding frame to the target gene. Despite this effect, we were able to isolate T2A-Gal4 insertions in four genes that serve as in vivo expression reporters. Therefore, homology-independent insertion in Drosophila is a fast and simple alternative to HDR that will enable researchers to dissect gene function.
1) Discovery of over 1 million structural variant calls from 30+ sequence-resolved callsets across 4 technologies for an AJ Trio. 2) After clustering, over 128,000 sequence-resolved SV calls >=50bp remained. 3) Over 30,000 SVs had support from 2+ technologies or 5+ callers with sequences <20% different or support from optical mapping.
RNA-based screening in drug discovery – introducing sgRNA technologiesCandy Smellie
RNA-based screening in drug discovery
Use of X-MAN™ isogenic cell lines in RNAi screening approaches
Comparison of siRNA and sgRNA screening approaches
The challenges of genome-wide CRISPR-Cas9 knockout (GeCKO) screening
Using CRISPR-Cas9 sgRNA for target identification and patient stratification
Moving from screening hit to target validation
sgRNA screening: not just KOs
The document summarizes the results of adding long read and linked read sequencing data to the Genome in a Bottle Consortium benchmark. Specifically:
- The benchmark regions now cover over 90% of the genome and include over 139,000 additional SNPs and 16,000 more insertions/deletions, mostly in difficult to sequence regions.
- The additional data improves variant detection in medically relevant genes and reduces errors compared to using short reads alone.
- However, performance of short read variant callers decreases when evaluated against the new expanded benchmark, highlighting remaining challenges in complex genomic regions.
Integration of long reads and linked reads generated a new draft Genome in a Bottle variant benchmark, adding over 276,840 SNPs and 42,980 indels, mostly in difficult to map regions. The new benchmark provides improved coverage of genes and duplications. Preliminary results show the new variants improve performance of variant calling in difficult regions compared to the previous benchmark based on short reads alone.
Dr. Chris Lowe presented on Horizon Discovery's precision genome editing platform called GENESISTM. The presentation discussed optimizing GENESISTM by combining CRISPR and rAAV technologies to improve gene targeting efficiency. Custom cell line development services are offered to modify genes of interest in various cell lines for applications such as generating disease models and studying drug sensitivity. Key considerations for successful gene editing experiments include factors like gene/cell line selection, gRNA design/activity, donor design, screening/validation approaches. Case studies demonstrated applications of engineered cell lines.
Introduction and key considerations around gene-editing using CRISPR and rAAV.
With an overview of our knock-out library using the haploid cell line HAP1
This document provides guidance on planning and executing successful siRNA experiments through following good practices. It reviews key steps including understanding the target transcript through identifying variants and structures, selecting effective siRNAs using design tools and rules, choosing a cell line with appropriate expression profiles, optimizing experimental conditions through controls and pilot experiments, and validating the assay. Following these steps can help achieve optimized gene knockdown.
New methods draft v4alpha small variant benchmarkGenomeInABottle
The document summarizes efforts to expand the Genome in a Bottle (GIAB) benchmark reference datasets using long-read and linked-read sequencing technologies. Initial results found PacBio and 10X Genomics data could add over 385,000 new benchmark SNPs and 71,000 indels, mostly in difficult to map regions. Comparison to Illumina data found recall decreased 10-fold in some regions, due to new variants identified, while precision remained high. Ongoing work includes improving variant calling in repeats and developing machine learning methods to further refine the benchmark datasets.
1) Discovery of over 1 million structural variant calls from 30+ sequence-resolved callsets across 4 technologies for an AJ Trio. 2) After clustering, over 128,000 sequence-resolved SV calls >=50bp remained. 3) Over 30,000 SVs had support from 2+ technologies or 5+ callers with sequences <20% different or support from optical mapping.
RNA-based screening in drug discovery – introducing sgRNA technologiesCandy Smellie
RNA-based screening in drug discovery
Use of X-MAN™ isogenic cell lines in RNAi screening approaches
Comparison of siRNA and sgRNA screening approaches
The challenges of genome-wide CRISPR-Cas9 knockout (GeCKO) screening
Using CRISPR-Cas9 sgRNA for target identification and patient stratification
Moving from screening hit to target validation
sgRNA screening: not just KOs
The document summarizes the results of adding long read and linked read sequencing data to the Genome in a Bottle Consortium benchmark. Specifically:
- The benchmark regions now cover over 90% of the genome and include over 139,000 additional SNPs and 16,000 more insertions/deletions, mostly in difficult to sequence regions.
- The additional data improves variant detection in medically relevant genes and reduces errors compared to using short reads alone.
- However, performance of short read variant callers decreases when evaluated against the new expanded benchmark, highlighting remaining challenges in complex genomic regions.
Integration of long reads and linked reads generated a new draft Genome in a Bottle variant benchmark, adding over 276,840 SNPs and 42,980 indels, mostly in difficult to map regions. The new benchmark provides improved coverage of genes and duplications. Preliminary results show the new variants improve performance of variant calling in difficult regions compared to the previous benchmark based on short reads alone.
Dr. Chris Lowe presented on Horizon Discovery's precision genome editing platform called GENESISTM. The presentation discussed optimizing GENESISTM by combining CRISPR and rAAV technologies to improve gene targeting efficiency. Custom cell line development services are offered to modify genes of interest in various cell lines for applications such as generating disease models and studying drug sensitivity. Key considerations for successful gene editing experiments include factors like gene/cell line selection, gRNA design/activity, donor design, screening/validation approaches. Case studies demonstrated applications of engineered cell lines.
Introduction and key considerations around gene-editing using CRISPR and rAAV.
With an overview of our knock-out library using the haploid cell line HAP1
This document provides guidance on planning and executing successful siRNA experiments through following good practices. It reviews key steps including understanding the target transcript through identifying variants and structures, selecting effective siRNAs using design tools and rules, choosing a cell line with appropriate expression profiles, optimizing experimental conditions through controls and pilot experiments, and validating the assay. Following these steps can help achieve optimized gene knockdown.
New methods draft v4alpha small variant benchmarkGenomeInABottle
The document summarizes efforts to expand the Genome in a Bottle (GIAB) benchmark reference datasets using long-read and linked-read sequencing technologies. Initial results found PacBio and 10X Genomics data could add over 385,000 new benchmark SNPs and 71,000 indels, mostly in difficult to map regions. Comparison to Illumina data found recall decreased 10-fold in some regions, due to new variants identified, while precision remained high. Ongoing work includes improving variant calling in repeats and developing machine learning methods to further refine the benchmark datasets.
Recent breakthroughs in genome editing technology have led to a rapid adoption that parallels that seen with RNAi. And like RNAi, these methods are taking the scientific world by storm, with high profile publications in fields as diverse as HIV treatment, stem cell therapy, food crop modification and drug development to name but a few.
Critically, the endogenous modification of genes enables the study of their function in a physiological context. It also overcomes some of the artefacts that can result from established techniques such as transgenesis and RNAi, which have mislead researchers with false positives or negatives. Until recently however genome editing required considerable technical expertise, and consequently was a relatively niche pursuit.
In this talk we will look at how the latest developments in genome editing tools have changed this, with improvements in both ease-of-use and targeting efficiency, as well as a concomitant reduction in costs opening up these approaches to the wider scientific community.
Rapid adoption of the CRISPR/Cas9 system has for example led to a long list of organisms and tissues in which genetic changes have been made with high efficiency. Other technologies such as recombinant adeno-associated virus (rAAV) offer further precision, stimulating the cell’s high-fidelity DNA repair pathways to insert exogenous sequence with unrivalled specificity. Targeting efficiency can be improved still further by using the technologies in combination – genome cutting induced by CRISPR can significantly enhance homologous recombination mediated by rAAV.
Despite these rapid advances, some pitfalls remain, and so we’ll discuss some of the key considerations for avoiding these, ranging from simply picking the right tool for the job to designing an experiment that maximises chances of success.
Finally we’ll look at how genome editing is being applied to both basic and translational research, and in both a gene-specific and genome wide manner. For the study of disease associated genes and mutations scientists can now complement wide panels of tumour cells with genetically defined isogenic cell pairs identical in all but precise modifications in their gene of interest. The ease-of-design and efficiency of the CRISPR system is also being exploited for genome wide synthetic lethality screens, facilitating rapid drug target identification with significantly reduced risk of false negatives and off-target false positives. And again, further synergies are achieved when these approaches are combined to look for potential synthetic lethal targets in specific genomic contexts.
1) Discovery: Over 1 million structural variant calls were discovered across 30 sequence-resolved callsets from 4 technologies for an AJ Trio. After clustering, over 128,000 sequence-resolved calls remained.
2) Discovery Support: Over 30,000 structural variants had support from 2+ technologies or 5+ callers in the trio.
3) Evaluate/genotype: Nearly 20,000 structural variants had a consensus variant genotype predicted for the son from analyzing the trio.
Recent advances in CRISPR-CAS9 technology: an alternative to transgenic breedingJyoti Prakash Sahoo
These are the part of the Bacterial immune system which detects and recognize the foreign DNA and cleaves it.
THE CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) loci
Cas (CRISPR- associated) proteins can target and cleave invading DNA in a sequence – specific manner.
CRISPR array is composed of a series of repeats interspaced by spacer sequences acquired from invading genomes.
CRISPR/Cas9 gene editing is based on a microbial restriction system, that has been harnessed for genome targeting using only a short sequence of RNA as a guide.
GENESIS™: Comprehensive genome editing - Translating genetic information into personalised medicines.
Horizon is the only source of rAAV expertise and is uniquely capable of exploiting multiple platforms: CRISPR, ZFNs and rAAV singularly or combined. Horizon’s scientists are experts at all forms of gene editing and so have the experience to help guide customers towards the approach that best suits their project
The CRISPR/Cas9 system has emerged as one of the leading tools for modifying the genomes of organisms ranging from E. coli to humans. In this presentation, we discuss various methods for generating the crRNA and tracrRNA components that are required for guiding the Cas9 endonuclease to genomic targets. You will also learn how to optimize a new 2-part CRISPR RNA system from IDT that offers multiple benefits over other technologies.
This document summarizes a presentation about assembling the major histocompatibility complex (MHC) region of the human genome. It discusses the importance of accurately phasing HLA genes in the MHC region for organ transplantation matching. It describes using long reads, trio sequencing data, and other techniques to generate "perfect" haplotig assemblies of the MHC region with fully phased HLA genes. It acknowledges some remaining challenges like resolving repeats and integrating assembly and mapping-based variant calls to create the most accurate reference. The goal is to solve the complex MHC puzzle at scale using long read technologies to create a next-generation MHC database.
Thousands of different long non-coding RNAs (lncRNAs) exist in mammalian cells. lncRNAs do not encode proteins but can be very important for cell function. Studying their functions can be difficult because of their diverse modes of action. One method to discern cellular function is by selective knockdown of a specific lncRNA species. However, achieving consistent knockdown has proven to be more challenging for lncRNAs than for mRNAs or miRNAs. In this presentation, we discuss some of the issues encountered with lncRNA research. We cover antisense oligonucleotide (ASO) and small interfering RNA (siRNA) methods for lncRNA knockdown. And, we show how cellular localization of a specific lncRNA target informs the choice of knockdown method.
Genome engineering using CRISPR/Cas9 has several advantages over traditional gene targeting methods: it is faster, more precise, applicable to many species, and less expensive. CRISPR/Cas9 uses the Cas9 nuclease guided by a single guide RNA to introduce double-strand breaks at targeted genomic loci. This can generate gene knockouts through error-prone non-homologous end joining or allow for targeted insertions and modifications through homology-directed repair. While CRISPR/Cas9 has great potential, careful design of guide RNAs and donor templates is needed to minimize off-target effects.
Increasing the efficiency of homology-directed repair for crispr-cas9-induced...Hamza Khan
This document discusses using CRISPR-Cas9 gene editing to precisely modify genes in mammalian cells. It finds that suppressing non-homologous end joining (NHEJ) DNA repair increases the efficiency of homology-directed repair (HDR) for precise gene editing. Knocking down proteins involved in NHEJ, like KU70, KU80, and DNA ligase IV, increases the fraction of cells repaired by HDR up to 5-fold. Inhibiting ligase IV with SCR7 or expressing adenovirus proteins also increases HDR up to 7-fold while decreasing NHEJ repairs. This enhanced HDR could enable more efficient gene correction and targeted mutagenesis in cells
Genome Editing Comes of Age; CRISPR, rAAV and the new landscape of molecular ...Candy Smellie
Information is no longer a bottleneck, emphasis is shifting to the ‘what does it all mean’
In a translational context we hope that by answering that question we will be able to is to characterise the genetics that drive disease, and indeed develop drugs and diagnostics that are personalised to patients.
Genome editing provides the link between the information here, and this outcome here, by allowing scientists to recapitulate specific genetic alterations in any gene in any living tissue to probe function, develop disease models and identify therapeutic strategies. So, not only do we now have unparalleled access to genetic information, but we now have the tools to most accuartely understand what this genetic information – with genome editing allowing us to explore the genetic drivers of disease in physiological models.
AAV is a single-stranded, linear DNA virus with a a 4.7 kb genome which for the purpose of genome editing is replaced almost in entirety with the targeting vector sequence (except for the iTRs)
It is in effect a highly effective DNA delivery mechanism
After entry of the vector into the cell, target-specific homologous DNA is believed to activate and recruit HR-dependent repair factors can induce HR at rates approximately 1,000 times greater than plasmid based double stranded DNA vectors, but the mechanism by which it achieves this is still largely unknown
By including a selection cassette can select for cells that have integrated the targeting vector, and then screen for clones which have undergone targeted insetion rather than random integration, which will generally be around 1%.
CRISPR/Cas9 gene editing is based on a microbial restriction system, that has been harnessed for genome targeting using only a short sequence of RNA as a guide.
The beauty of the system is that unlike protein binding based technologies such as Zinc Fingers and TALENs which require complex protein engineering, the design rules are very simple, and it is this fact that is allowing CRISPR to take genome engineering from a relatively niche persuit to the mainstream scientific community.
The principle of the system is that a short guide RNA, homologous to the target site recruits a nuclease – Cas9
This then cuts the dsDNA, triggering repair by either the low fidelity NHEJ pathway, or by HDR in the presence of an exogenous donor sequence.
High Efficiencies for both knockouts and knock-ins have been reported and whilst there are understandable concerns about specificity, new methodologies to address these are now being developed
The system itself is comprised of three key components
the Cas9 protein, which cuts/cleaves the DNA and
Two RNAs - a crispr RNA contains the sequence homologous to the target site and a trans-activating crisprRNA (or TracrRNA) which recruits the nuclease/crispr complex
For genome editing, the crisperRNA and TraceRNA are generally now constructed together into a single guideRNA or sgRNA
Genome editing is elicited through hybridization of the sgRNA with its matching genomic sequence, and the recruitment of the Cas9, which cleaves at the target site.
This document discusses RNA interference (RNAi) techniques such as silencing RNA and CRISPR/Cas9. It explains that double-stranded RNA is cut by the enzyme Dicer into short interfering RNAs (siRNAs) that can degrade mRNA strands in a highly specific process. RNAi is involved in regulating 30% of the human genome and acts as a defense mechanism against viruses and transposons. The document also discusses selecting effective siRNAs, considerations for species variation and secondary RNA structures, and strategies for gene knockdown screening using shRNA and CRISPR/Cas9.
CRISPR-Cas9 is a powerful tool for genome engineering. The document provides guidance on using CRISPR-Cas9 to modify genomes. It describes: 1) Designing single guide RNAs (sgRNAs) to target specific gene loci using online tools; 2) Constructing plasmids expressing Cas9 and sgRNAs; 3) Validating plasmid function using assays like Surveyor nuclease; and 4) Transfecting cells, isolating clones, and further validating genome edits through sequencing. The goal is to use this method to precisely modify genomes for research applications.
Ga4gh 2019 - Assuring data quality with benchmarking tools from GIAB and GA4GHGenomeInABottle
1. The document discusses benchmarking tools from GIAB and GA4GH that help clinical genomics labs validate variant calling methods and sequencing performance using NIST human genome reference materials.
2. It describes challenges with current benchmarking capabilities including a lack of GRCh38 resources and difficult to interpret outputs, and efforts to address these such as new benchmark sets for more challenging regions and a simplified benchmarking report.
3. Future work is focused on developing new structural variant benchmarks, benchmarking against both GRCh37 and GRCh38, and benchmarking somatic and diploid variants.
The Genoox integrated SV platform combines optical genome mapping using Saphyr with next-generation sequencing data to detect structural variants with high sensitivity and specificity. It considers variants identified through both approaches simultaneously throughout the calling pipeline for refined breakpoint positions. Comparison to the GIAB v0.6 truth set showed the Genoox caller identified 1076 true positives out of 1285 variants in high-confidence regions, with 95% of putative false positives actually being correct comparisons and 87% of putative false negatives falling outside Bionano-covered regions.
The document provides an overview of gene knockout and homology-directed repair using CRISPR. It discusses designing guide RNAs and comparing delivery methods like lipofection, electroporation, and microinjection. It also covers designing repair templates for homology-directed repair to insert or change DNA sequences. Optimization of guide RNAs, delivery method, and repair template design can improve genome editing efficiency.
This document summarizes the Genome in a Bottle (GIAB) project, which develops reference materials and benchmarks for evaluating human genome sequencing and variant detection. GIAB has characterized 7 human genomes to high accuracy using diverse sequencing technologies. It provides extensive public sequencing data for benchmarking along with well-characterized variants. GIAB aims to improve benchmarks for difficult variants using linked reads, long reads, and diploid genome assemblies. The project collaborates widely and its reference materials and data are openly available to support innovation in genome sequencing and analysis.
Alzheimer’s disease (AD) is a devastating neurodegenerative disease that is genetically complex. Although great progress has been made in identifying fully penetrant mutations in genes that cause early-onset AD, these still represent a very small percentage of AD cases. Large-scale, genome-wide association studies (GWAS) have identified at least 20 additional genetic risk loci for the more common form: late-onset AD. However, the identified SNPs are typically not the actual risk variants, but are in linkage disequilibrium with the presumed causative variants [1].
To help identify causative genetic variants, we have combined highly accurate, long-read sequencing with hybrid-capture technology. In this collaborative webinar*, we present this method and show how combining IDT xGen® Lockdown® Probes with PacBio SMRT® Sequencing allows targeting and sequencing of candidate genes from genomic DNA and corresponding transcripts from cDNA. Using a panel of target capture probes for 35 AD candidate genes, we demonstrate the power of this approach by looking at data for two individuals with AD. Some additional benefits of this method include the ability to leverage long reads, phase heterozygous variants, and link corresponding transcript isoforms to their respective alleles.
Reference: 1. Van Cauwenberghe C, Van Broeckhoven C, Sleegers K. (2016) The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med, 18(5):421–430.
* This presentation represents a collaboration between Pacific Biosciences and Integrated DNA Technologies. The individual opinions expressed may not reflect shared opinions of Pacific Biosciences and Integrated DNA Technologies.
Genome in a bottle for ashg grc giab workshop 181016GenomeInABottle
Genome in a Bottle (GIAB) provides benchmark genomes to evaluate the accuracy of variant calling from whole genome sequencing. GIAB has characterized 7 human genomes to date, including difficult variants. The benchmark calls continue to evolve as new data and methods are integrated. While current benchmarks enable validation of "easier" variants, GIAB is working to characterize more difficult variants and regions. This will allow validation of clinical tests focused on difficult sites. GIAB data and analyses are openly available to support method development and technology optimization.
Have you considered that protein over-expression or inefficient mRNA knockdown may be masking physiological effects in your assays? Increasingly scientists are moving to endogenous gene-editing to characterise the function of their genes of interest.
Dr Chris Thorne from Cambridge Biotech Horizon Discovery discusses the ground breaking gene-editing technology CRISPR. The simplicity of experimental design has led to rapid adoption of the technology across the scientific community. However, challenges remain.
This Slidedeck focuses specifically on implementing CRISPR experiments, and explore a number of key considerations crucial to maximising chances of targeting success, whether your goal is to generate a knock-out or a knock-in. Chris also takes a look at some of the alternative uses of CRISPR, including sgRNA genome wide synthetic lethality screens.
The slides aim to support those researchers either planning to or already using CRISPR gene-editing in their lab. Horizon Discovery have also recently launched a program aimed specifically at academic cell biologists to promote the adoption of CRISPR by offering FREE CRISPR Reagents for knock-out cell line generation - more information available here. http://www.horizondiscovery.com/what-we-do/discovery-toolbox/genassist-crispr--raav-genome-editing-tools
i explained about basics of genome engineering and crispr system.
CRISPR will change the world and it is just the beginning, are you ready to meet the future? you think its great and beautiful or.....?
please give your feedback to my email
pooyanaghshbandi@yahoo.com
i am starting to write a critical and fantastic review article about CRISPR, if you are interested to join please contact me.
Recent breakthroughs in genome editing technology have led to a rapid adoption that parallels that seen with RNAi. And like RNAi, these methods are taking the scientific world by storm, with high profile publications in fields as diverse as HIV treatment, stem cell therapy, food crop modification and drug development to name but a few.
Critically, the endogenous modification of genes enables the study of their function in a physiological context. It also overcomes some of the artefacts that can result from established techniques such as transgenesis and RNAi, which have mislead researchers with false positives or negatives. Until recently however genome editing required considerable technical expertise, and consequently was a relatively niche pursuit.
In this talk we will look at how the latest developments in genome editing tools have changed this, with improvements in both ease-of-use and targeting efficiency, as well as a concomitant reduction in costs opening up these approaches to the wider scientific community.
Rapid adoption of the CRISPR/Cas9 system has for example led to a long list of organisms and tissues in which genetic changes have been made with high efficiency. Other technologies such as recombinant adeno-associated virus (rAAV) offer further precision, stimulating the cell’s high-fidelity DNA repair pathways to insert exogenous sequence with unrivalled specificity. Targeting efficiency can be improved still further by using the technologies in combination – genome cutting induced by CRISPR can significantly enhance homologous recombination mediated by rAAV.
Despite these rapid advances, some pitfalls remain, and so we’ll discuss some of the key considerations for avoiding these, ranging from simply picking the right tool for the job to designing an experiment that maximises chances of success.
Finally we’ll look at how genome editing is being applied to both basic and translational research, and in both a gene-specific and genome wide manner. For the study of disease associated genes and mutations scientists can now complement wide panels of tumour cells with genetically defined isogenic cell pairs identical in all but precise modifications in their gene of interest. The ease-of-design and efficiency of the CRISPR system is also being exploited for genome wide synthetic lethality screens, facilitating rapid drug target identification with significantly reduced risk of false negatives and off-target false positives. And again, further synergies are achieved when these approaches are combined to look for potential synthetic lethal targets in specific genomic contexts.
1) Discovery: Over 1 million structural variant calls were discovered across 30 sequence-resolved callsets from 4 technologies for an AJ Trio. After clustering, over 128,000 sequence-resolved calls remained.
2) Discovery Support: Over 30,000 structural variants had support from 2+ technologies or 5+ callers in the trio.
3) Evaluate/genotype: Nearly 20,000 structural variants had a consensus variant genotype predicted for the son from analyzing the trio.
Recent advances in CRISPR-CAS9 technology: an alternative to transgenic breedingJyoti Prakash Sahoo
These are the part of the Bacterial immune system which detects and recognize the foreign DNA and cleaves it.
THE CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) loci
Cas (CRISPR- associated) proteins can target and cleave invading DNA in a sequence – specific manner.
CRISPR array is composed of a series of repeats interspaced by spacer sequences acquired from invading genomes.
CRISPR/Cas9 gene editing is based on a microbial restriction system, that has been harnessed for genome targeting using only a short sequence of RNA as a guide.
GENESIS™: Comprehensive genome editing - Translating genetic information into personalised medicines.
Horizon is the only source of rAAV expertise and is uniquely capable of exploiting multiple platforms: CRISPR, ZFNs and rAAV singularly or combined. Horizon’s scientists are experts at all forms of gene editing and so have the experience to help guide customers towards the approach that best suits their project
The CRISPR/Cas9 system has emerged as one of the leading tools for modifying the genomes of organisms ranging from E. coli to humans. In this presentation, we discuss various methods for generating the crRNA and tracrRNA components that are required for guiding the Cas9 endonuclease to genomic targets. You will also learn how to optimize a new 2-part CRISPR RNA system from IDT that offers multiple benefits over other technologies.
This document summarizes a presentation about assembling the major histocompatibility complex (MHC) region of the human genome. It discusses the importance of accurately phasing HLA genes in the MHC region for organ transplantation matching. It describes using long reads, trio sequencing data, and other techniques to generate "perfect" haplotig assemblies of the MHC region with fully phased HLA genes. It acknowledges some remaining challenges like resolving repeats and integrating assembly and mapping-based variant calls to create the most accurate reference. The goal is to solve the complex MHC puzzle at scale using long read technologies to create a next-generation MHC database.
Thousands of different long non-coding RNAs (lncRNAs) exist in mammalian cells. lncRNAs do not encode proteins but can be very important for cell function. Studying their functions can be difficult because of their diverse modes of action. One method to discern cellular function is by selective knockdown of a specific lncRNA species. However, achieving consistent knockdown has proven to be more challenging for lncRNAs than for mRNAs or miRNAs. In this presentation, we discuss some of the issues encountered with lncRNA research. We cover antisense oligonucleotide (ASO) and small interfering RNA (siRNA) methods for lncRNA knockdown. And, we show how cellular localization of a specific lncRNA target informs the choice of knockdown method.
Genome engineering using CRISPR/Cas9 has several advantages over traditional gene targeting methods: it is faster, more precise, applicable to many species, and less expensive. CRISPR/Cas9 uses the Cas9 nuclease guided by a single guide RNA to introduce double-strand breaks at targeted genomic loci. This can generate gene knockouts through error-prone non-homologous end joining or allow for targeted insertions and modifications through homology-directed repair. While CRISPR/Cas9 has great potential, careful design of guide RNAs and donor templates is needed to minimize off-target effects.
Increasing the efficiency of homology-directed repair for crispr-cas9-induced...Hamza Khan
This document discusses using CRISPR-Cas9 gene editing to precisely modify genes in mammalian cells. It finds that suppressing non-homologous end joining (NHEJ) DNA repair increases the efficiency of homology-directed repair (HDR) for precise gene editing. Knocking down proteins involved in NHEJ, like KU70, KU80, and DNA ligase IV, increases the fraction of cells repaired by HDR up to 5-fold. Inhibiting ligase IV with SCR7 or expressing adenovirus proteins also increases HDR up to 7-fold while decreasing NHEJ repairs. This enhanced HDR could enable more efficient gene correction and targeted mutagenesis in cells
Genome Editing Comes of Age; CRISPR, rAAV and the new landscape of molecular ...Candy Smellie
Information is no longer a bottleneck, emphasis is shifting to the ‘what does it all mean’
In a translational context we hope that by answering that question we will be able to is to characterise the genetics that drive disease, and indeed develop drugs and diagnostics that are personalised to patients.
Genome editing provides the link between the information here, and this outcome here, by allowing scientists to recapitulate specific genetic alterations in any gene in any living tissue to probe function, develop disease models and identify therapeutic strategies. So, not only do we now have unparalleled access to genetic information, but we now have the tools to most accuartely understand what this genetic information – with genome editing allowing us to explore the genetic drivers of disease in physiological models.
AAV is a single-stranded, linear DNA virus with a a 4.7 kb genome which for the purpose of genome editing is replaced almost in entirety with the targeting vector sequence (except for the iTRs)
It is in effect a highly effective DNA delivery mechanism
After entry of the vector into the cell, target-specific homologous DNA is believed to activate and recruit HR-dependent repair factors can induce HR at rates approximately 1,000 times greater than plasmid based double stranded DNA vectors, but the mechanism by which it achieves this is still largely unknown
By including a selection cassette can select for cells that have integrated the targeting vector, and then screen for clones which have undergone targeted insetion rather than random integration, which will generally be around 1%.
CRISPR/Cas9 gene editing is based on a microbial restriction system, that has been harnessed for genome targeting using only a short sequence of RNA as a guide.
The beauty of the system is that unlike protein binding based technologies such as Zinc Fingers and TALENs which require complex protein engineering, the design rules are very simple, and it is this fact that is allowing CRISPR to take genome engineering from a relatively niche persuit to the mainstream scientific community.
The principle of the system is that a short guide RNA, homologous to the target site recruits a nuclease – Cas9
This then cuts the dsDNA, triggering repair by either the low fidelity NHEJ pathway, or by HDR in the presence of an exogenous donor sequence.
High Efficiencies for both knockouts and knock-ins have been reported and whilst there are understandable concerns about specificity, new methodologies to address these are now being developed
The system itself is comprised of three key components
the Cas9 protein, which cuts/cleaves the DNA and
Two RNAs - a crispr RNA contains the sequence homologous to the target site and a trans-activating crisprRNA (or TracrRNA) which recruits the nuclease/crispr complex
For genome editing, the crisperRNA and TraceRNA are generally now constructed together into a single guideRNA or sgRNA
Genome editing is elicited through hybridization of the sgRNA with its matching genomic sequence, and the recruitment of the Cas9, which cleaves at the target site.
This document discusses RNA interference (RNAi) techniques such as silencing RNA and CRISPR/Cas9. It explains that double-stranded RNA is cut by the enzyme Dicer into short interfering RNAs (siRNAs) that can degrade mRNA strands in a highly specific process. RNAi is involved in regulating 30% of the human genome and acts as a defense mechanism against viruses and transposons. The document also discusses selecting effective siRNAs, considerations for species variation and secondary RNA structures, and strategies for gene knockdown screening using shRNA and CRISPR/Cas9.
CRISPR-Cas9 is a powerful tool for genome engineering. The document provides guidance on using CRISPR-Cas9 to modify genomes. It describes: 1) Designing single guide RNAs (sgRNAs) to target specific gene loci using online tools; 2) Constructing plasmids expressing Cas9 and sgRNAs; 3) Validating plasmid function using assays like Surveyor nuclease; and 4) Transfecting cells, isolating clones, and further validating genome edits through sequencing. The goal is to use this method to precisely modify genomes for research applications.
Ga4gh 2019 - Assuring data quality with benchmarking tools from GIAB and GA4GHGenomeInABottle
1. The document discusses benchmarking tools from GIAB and GA4GH that help clinical genomics labs validate variant calling methods and sequencing performance using NIST human genome reference materials.
2. It describes challenges with current benchmarking capabilities including a lack of GRCh38 resources and difficult to interpret outputs, and efforts to address these such as new benchmark sets for more challenging regions and a simplified benchmarking report.
3. Future work is focused on developing new structural variant benchmarks, benchmarking against both GRCh37 and GRCh38, and benchmarking somatic and diploid variants.
The Genoox integrated SV platform combines optical genome mapping using Saphyr with next-generation sequencing data to detect structural variants with high sensitivity and specificity. It considers variants identified through both approaches simultaneously throughout the calling pipeline for refined breakpoint positions. Comparison to the GIAB v0.6 truth set showed the Genoox caller identified 1076 true positives out of 1285 variants in high-confidence regions, with 95% of putative false positives actually being correct comparisons and 87% of putative false negatives falling outside Bionano-covered regions.
The document provides an overview of gene knockout and homology-directed repair using CRISPR. It discusses designing guide RNAs and comparing delivery methods like lipofection, electroporation, and microinjection. It also covers designing repair templates for homology-directed repair to insert or change DNA sequences. Optimization of guide RNAs, delivery method, and repair template design can improve genome editing efficiency.
This document summarizes the Genome in a Bottle (GIAB) project, which develops reference materials and benchmarks for evaluating human genome sequencing and variant detection. GIAB has characterized 7 human genomes to high accuracy using diverse sequencing technologies. It provides extensive public sequencing data for benchmarking along with well-characterized variants. GIAB aims to improve benchmarks for difficult variants using linked reads, long reads, and diploid genome assemblies. The project collaborates widely and its reference materials and data are openly available to support innovation in genome sequencing and analysis.
Alzheimer’s disease (AD) is a devastating neurodegenerative disease that is genetically complex. Although great progress has been made in identifying fully penetrant mutations in genes that cause early-onset AD, these still represent a very small percentage of AD cases. Large-scale, genome-wide association studies (GWAS) have identified at least 20 additional genetic risk loci for the more common form: late-onset AD. However, the identified SNPs are typically not the actual risk variants, but are in linkage disequilibrium with the presumed causative variants [1].
To help identify causative genetic variants, we have combined highly accurate, long-read sequencing with hybrid-capture technology. In this collaborative webinar*, we present this method and show how combining IDT xGen® Lockdown® Probes with PacBio SMRT® Sequencing allows targeting and sequencing of candidate genes from genomic DNA and corresponding transcripts from cDNA. Using a panel of target capture probes for 35 AD candidate genes, we demonstrate the power of this approach by looking at data for two individuals with AD. Some additional benefits of this method include the ability to leverage long reads, phase heterozygous variants, and link corresponding transcript isoforms to their respective alleles.
Reference: 1. Van Cauwenberghe C, Van Broeckhoven C, Sleegers K. (2016) The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med, 18(5):421–430.
* This presentation represents a collaboration between Pacific Biosciences and Integrated DNA Technologies. The individual opinions expressed may not reflect shared opinions of Pacific Biosciences and Integrated DNA Technologies.
Genome in a bottle for ashg grc giab workshop 181016GenomeInABottle
Genome in a Bottle (GIAB) provides benchmark genomes to evaluate the accuracy of variant calling from whole genome sequencing. GIAB has characterized 7 human genomes to date, including difficult variants. The benchmark calls continue to evolve as new data and methods are integrated. While current benchmarks enable validation of "easier" variants, GIAB is working to characterize more difficult variants and regions. This will allow validation of clinical tests focused on difficult sites. GIAB data and analyses are openly available to support method development and technology optimization.
Have you considered that protein over-expression or inefficient mRNA knockdown may be masking physiological effects in your assays? Increasingly scientists are moving to endogenous gene-editing to characterise the function of their genes of interest.
Dr Chris Thorne from Cambridge Biotech Horizon Discovery discusses the ground breaking gene-editing technology CRISPR. The simplicity of experimental design has led to rapid adoption of the technology across the scientific community. However, challenges remain.
This Slidedeck focuses specifically on implementing CRISPR experiments, and explore a number of key considerations crucial to maximising chances of targeting success, whether your goal is to generate a knock-out or a knock-in. Chris also takes a look at some of the alternative uses of CRISPR, including sgRNA genome wide synthetic lethality screens.
The slides aim to support those researchers either planning to or already using CRISPR gene-editing in their lab. Horizon Discovery have also recently launched a program aimed specifically at academic cell biologists to promote the adoption of CRISPR by offering FREE CRISPR Reagents for knock-out cell line generation - more information available here. http://www.horizondiscovery.com/what-we-do/discovery-toolbox/genassist-crispr--raav-genome-editing-tools
i explained about basics of genome engineering and crispr system.
CRISPR will change the world and it is just the beginning, are you ready to meet the future? you think its great and beautiful or.....?
please give your feedback to my email
pooyanaghshbandi@yahoo.com
i am starting to write a critical and fantastic review article about CRISPR, if you are interested to join please contact me.
We previously reported a CRISPR-mediated knock-in strategy into introns of Drosophila genes, generating an attP-FRT-SA T2A-GAL4-polyA-3XP3-EGFP-FRT-attP transgenic library for multiple uses (Lee et al., 2018a). The method relied on double stranded DNA (dsDNA) homology donors with ~1 kb homology arms. Here, we describe three new simpler ways to edit genes in flies. We create single stranded DNA (ssDNA) donors using PCR and add 100 nt of homology on each side of an integration cassette, followed by enzymatic removal of one strand. Using this method, we generated GFP-tagged proteins that mark organelles in S2 cells. We then describe two dsDNA methods using cheap synthesized donors flanked by 100 nt homology arms and gRNA target sites cloned into a plasmid. Upon injection, donor DNA (1 to 5 kb) is released from the plasmid by Cas9. The cassette integrates efficiently and precisely in vivo. The approach is fast, cheap, and scalable.
This document summarizes information about the CRISPR Cas9 genome editing tool. It discusses how CRISPR Cas9 uses guide RNA and the Cas9 enzyme to create targeted double-strand breaks in DNA, allowing genes to be knocked out or altered. The document outlines the history and mechanism of CRISPR Cas9, compares it to other genome editing tools, discusses its applications in plant breeding including reducing off-target effects, and provides an example of using it to create parthenocarpic tomato plants.
Speaker: Benedict C. S. Cross, PhD, Team leader (Discovery Screening), Horizon Discovery
CRISPR–Cas9 mediated genome editing provides a highly efficient way to probe gene function. Using this technology, thousands of genes can be knocked out and their function assessed in a single experiment. We have conducted over 150 of these complex and powerful screens and will use our experience to guide you through the process of screen design, performance and analysis.
We'll be discussing:
• How to use CRISPR screening for target ID and validation, understanding drug MOA and patient stratification
• The screen design, quality control and how to evaluate success of your screening program
• Horizon’s latest developments to the platform
• Horizon’s novel approaches to target validation screening
This document provides information on CRISPR Cas9 genome editing. It discusses the history and discovery of CRISPR dating back to 1987. It describes the key components of the CRISPR Cas9 system including Cas9 proteins, CRISPR RNA, protospacers, and PAM sequences. The mechanisms of how CRISPR Cas9 edits genomes through double strand breaks is explained. Finally, applications of CRISPR Cas9 are summarized, including using it to correct genetic mutations causing diseases in animals and potential applications in humans.
Present status and recent developments on available molecular marker.pptxPrabhatSingh628463
This document summarizes various molecular marker techniques used in genetics and plant breeding. It discusses restriction fragment length polymorphisms (RFLPs), randomly amplified polymorphic DNA (RAPDs), inter-simple sequence repeats (ISSRs), simple sequence repeats (SSRs), amplified fragment length polymorphisms (AFLPs), sequence-characterized amplified regions (SCARs), start codon targeted (SCoT) polymorphism analysis, and expressed sequence tags (ESTs). It also outlines applications of DNA markers such as fingerprinting, diversity studies, marker-assisted selection, genetic mapping, and gene tagging.
This document describes a novel gene targeting approach called aptamer-guided gene targeting (AGT) that uses DNA aptamers selected through capillary electrophoresis systematic evolution of ligands by exponential enrichment to bind site-specific DNA binding proteins and guide donor DNA to specific genetic loci for correction. The approach was shown to increase gene targeting efficiency up to 32-fold in yeast and 16-fold in human cells. It also discusses the potential to develop aptamers for other genome editing tools like CRISPR/Cas9.
A CRISPR/Cas9, works like a biological version of a word-processing programme’s “find and replace”. Its simplicity and extremely low cost of implementation is the reason to use. How Cas 9 is activated and its mechanism (DNA binding and cleavage), it's regulation and application in human disease therapy, new drug screening, agriculture and biofuel etc.
This presentation highlights the basics and application of genome editing strategies in plants, strategies to reduce off-target mutation, identification of mutant analysis etc.
The study of the complete set of RNAs (transcriptome) encoded by the genome of a specific cell or organism at a specific time or under a specific set of conditions is called Transcriptomics.
Transcriptomics aims:
I. To catalogue all species of transcripts, including mRNAs, noncoding RNAs and small RNAs.
II. To determine the transcriptional structure of genes, in terms of their start sites, 5′ and 3′ ends, splicing patterns and other post-transcriptional modifications.
III. To quantify the changing expression levels of each transcript during development and under different conditions.
Molecular markers can be used to characterize plant genetic resources and assist in pre-breeding for climate change. Various marker techniques are described, including hybridization-based RFLP and PCR-based RAPD, ISSR, SSR, AFLP, EST, and SCoT. Molecular markers reflect heritable DNA differences and have advantages like being ubiquitous, stable, and not affecting phenotypes. Data from markers can be analyzed to construct genetic similarity matrices and dendrograms to study genetic diversity and relationships. Molecular markers have applications in fingerprinting, diversity studies, marker-assisted selection, genetic mapping, and gene tagging.
Ø Researchers used CRISPR/Cas9 nuclease and nickase to target and repair the c.456+4A>T mutation in the FANCC gene, which causes Fanconi anemia (FA), in human fibroblasts derived from an FA patient.
Ø Both nuclease and nickase mediated repair of the mutation, restoring normal FANCC gene function, though nickase was more efficient due to preferentially inducing the homology-directed repair pathway.
Ø Genome-wide analyses found no off-target effects, confirming the CRISPR reagents specifically targeted the intended FANCC locus. This provides proof-of-principle that CR
This document summarizes Shivendra Kumar's class presentation on SNP genotyping using KASP. It introduces SNP genotyping and the KASP platform. It describes using KASP to genotype a wheat mapping population derived from a cross between an introgression line containing stripe rust resistance genes and a susceptible cultivar. KASP markers were developed and used to map the resistance genes. One candidate resistance gene was identified and further analyzed through expression studies and development of a linked KASP marker. Recombinants were identified and confirmed through additional KASP genotyping.
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)Akshay Deshmukh
clustered regularly interspaced short palindromic repeats is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria. Now CRISPR use as genome editing tool in different Plant Breeder to manipulate the DNA of the crop
This document summarizes a presentation on using CRISPR-Cas9 for crop improvement. It begins with an introduction to CRISPR-Cas9 and how it is used to edit genomes by removing, adding, or altering DNA sequences. It then discusses the mechanism of the CRISPR-Cas9 complex and how it creates breaks in DNA that are repaired. The document reviews several case studies where CRISPR was used to modify crops, including creating low-gluten wheat and improving rice. It finds that CRISPR can efficiently edit multiple genes simultaneously with few off-target effects. The conclusion states that CRISPR is revolutionizing agriculture by enabling the creation of higher yielding, more resistant crop varieties without transgenes.
Single Nucleotide Polymorphism Genotyping Using Kompetitive Allele Specific ...MANGLAM ARYA
Single Nucleotide Polymorphism
Single nucleotide polymorphism (SNP) refers to a single base change in a DNA sequence
SNP: Commonly biallelic
Two types(Based on presence in genome)
Synonymus
Non-synonymus
SNPs have largely replaced simple sequence repeats (SSRs)
Advantage of using SNPs
Low assay cost
High genomic abundance
Locus specificity
co-dominant inheritance
Simple documentation
Potential for high-throughput Analysis
Relatively low genotyping error rates
SNP genotyping platforms
BeadXpressTM,GoldenGateTM and Infinium from Illumina
GeneChipTM and GenFlexTM Tag array from Affimetrix
SNaPshotTM and TaqManTM from the Applied Biosystems
SNPWaveTM from KeyGene
iPLEX GoldTM Assay and Mass-RRAYTM from Sequonome
Variables to be considered
Throughput
Data turnaround
Time
Ease of use
Performance (sensitivity, reliability, reproducibility, and accuracy),
Flexibility (genotyping few samples with many snps or many samples with few snps),
Number of markers generated per run (uniplex versus multiplex assay capability)
Assay development requirements and genotyping cost per sample or data point.
KASP
KBioscience Competitive Allele-Specific PCR
Homogenous, Fluorescence-based genotyping technology, based on
Allele-specific oligo extension (primer)
Fluorescence resonance energy transfer
KASP Applications
Genotyping a wide range of species for various purposes.
KASP for Quality analysis, QTL mapping, MARS, and allele mining
Quality Control Analysis
QC analysis should be done for two reasons by genotyping the parents and F1s with the same subset of SNPs, in order to
confirm if F1s contains true-to-type alleles from their parents
check the genetic purity of the inbred parents.
F1s with true-to-type parental alleles for at least 90 % of the SNPs that were polymorphic between the parents should be advanced, while those with less than 10 % nonparental alleles should be discarded.
QTL Mapping
QTL mapping identifies a subset of markers that are significantly associated with one or more QTL influencing the expression of the trait of interest.
1) Select or develop a bi-parental mapping population.
2) Phenotype the population for a trait under greenhouse or field conditions.
3) Choose a molecular marking system – genotype parents of the mapping population and F1s with large numbers of markers, then select 200-400 markers exhibiting polymorphism between the parents.
4) Choose a genotyping approach, then generate molecular data for polymorphic markers
5) Identify the molecular markers associated with major QTL using statistical programs.
Large-scale allele mining
Allele mining is a promising approach to dissecting naturally occurring allelic variation at candidate genes controlling key agronomic traits.
KASP platform at CIMMYT has been used for the systematic mining of large germplasm collections for specific functional polymorphisms.
SNPs or small indels that
Molecular markers are DNA sequences that can be used to identify specific locations in the genome. They allow detection of differences between individuals. Common types of molecular markers include RFLP, RAPD, AFLP, SSR, and SNP. RFLP uses restriction enzymes and probes but requires a large amount of high quality DNA. RAPD uses PCR with random primers and needs little DNA but has low reproducibility. AFLP combines restriction enzymes and PCR for higher reproducibility. SSR and SNP detect differences in repetitive DNA sequences and single nucleotides, respectively. Molecular markers have various applications including measuring genetic diversity, fingerprinting, marker-assisted selection, and identifying genotypes.
Marker and marker assisted breeding in flower crops Tabinda Wani
Markers were used to track genes conferring resistance to disease in plant breeding programs. In one study, AFLP markers tracked the introgression of a resistance gene from a donor line into cultivated rose varieties over multiple generations of backcrossing. The individual with the lowest fraction of donor genome markers was selected for further backcrossing to reduce the donor genome. In another study, RAPD markers co-segregated with resistance to Fusarium in a petunia F2 population, identifying a marker linked to the resistance gene. A third study developed SSR markers from petunia expressed sequence tags and evaluated diversity in two F2 petunia populations to identify markers for future genetic mapping.
Similar to Homology independent insertion (CRISPaint) (20)
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...Sérgio Sacani
Context. With a mass exceeding several 104 M⊙ and a rich and dense population of massive stars, supermassive young star clusters
represent the most massive star-forming environment that is dominated by the feedback from massive stars and gravitational interactions
among stars.
Aims. In this paper we present the Extended Westerlund 1 and 2 Open Clusters Survey (EWOCS) project, which aims to investigate
the influence of the starburst environment on the formation of stars and planets, and on the evolution of both low and high mass stars.
The primary targets of this project are Westerlund 1 and 2, the closest supermassive star clusters to the Sun.
Methods. The project is based primarily on recent observations conducted with the Chandra and JWST observatories. Specifically,
the Chandra survey of Westerlund 1 consists of 36 new ACIS-I observations, nearly co-pointed, for a total exposure time of 1 Msec.
Additionally, we included 8 archival Chandra/ACIS-S observations. This paper presents the resulting catalog of X-ray sources within
and around Westerlund 1. Sources were detected by combining various existing methods, and photon extraction and source validation
were carried out using the ACIS-Extract software.
Results. The EWOCS X-ray catalog comprises 5963 validated sources out of the 9420 initially provided to ACIS-Extract, reaching a
photon flux threshold of approximately 2 × 10−8 photons cm−2
s
−1
. The X-ray sources exhibit a highly concentrated spatial distribution,
with 1075 sources located within the central 1 arcmin. We have successfully detected X-ray emissions from 126 out of the 166 known
massive stars of the cluster, and we have collected over 71 000 photons from the magnetar CXO J164710.20-455217.
When I was asked to give a companion lecture in support of ‘The Philosophy of Science’ (https://shorturl.at/4pUXz) I decided not to walk through the detail of the many methodologies in order of use. Instead, I chose to employ a long standing, and ongoing, scientific development as an exemplar. And so, I chose the ever evolving story of Thermodynamics as a scientific investigation at its best.
Conducted over a period of >200 years, Thermodynamics R&D, and application, benefitted from the highest levels of professionalism, collaboration, and technical thoroughness. New layers of application, methodology, and practice were made possible by the progressive advance of technology. In turn, this has seen measurement and modelling accuracy continually improved at a micro and macro level.
Perhaps most importantly, Thermodynamics rapidly became a primary tool in the advance of applied science/engineering/technology, spanning micro-tech, to aerospace and cosmology. I can think of no better a story to illustrate the breadth of scientific methodologies and applications at their best.
Current Ms word generated power point presentation covers major details about the micronuclei test. It's significance and assays to conduct it. It is used to detect the micronuclei formation inside the cells of nearly every multicellular organism. It's formation takes place during chromosomal sepration at metaphase.
Authoring a personal GPT for your research and practice: How we created the Q...Leonel Morgado
Thematic analysis in qualitative research is a time-consuming and systematic task, typically done using teams. Team members must ground their activities on common understandings of the major concepts underlying the thematic analysis, and define criteria for its development. However, conceptual misunderstandings, equivocations, and lack of adherence to criteria are challenges to the quality and speed of this process. Given the distributed and uncertain nature of this process, we wondered if the tasks in thematic analysis could be supported by readily available artificial intelligence chatbots. Our early efforts point to potential benefits: not just saving time in the coding process but better adherence to criteria and grounding, by increasing triangulation between humans and artificial intelligence. This tutorial will provide a description and demonstration of the process we followed, as two academic researchers, to develop a custom ChatGPT to assist with qualitative coding in the thematic data analysis process of immersive learning accounts in a survey of the academic literature: QUAL-E Immersive Learning Thematic Analysis Helper. In the hands-on time, participants will try out QUAL-E and develop their ideas for their own qualitative coding ChatGPT. Participants that have the paid ChatGPT Plus subscription can create a draft of their assistants. The organizers will provide course materials and slide deck that participants will be able to utilize to continue development of their custom GPT. The paid subscription to ChatGPT Plus is not required to participate in this workshop, just for trying out personal GPTs during it.
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdfSelcen Ozturkcan
Ozturkcan, S., Berndt, A., & Angelakis, A. (2024). Mending clothing to support sustainable fashion. Presented at the 31st Annual Conference by the Consortium for International Marketing Research (CIMaR), 10-13 Jun 2024, University of Gävle, Sweden.
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...Scintica Instrumentation
Targeting Hsp90 and its pathogen Orthologs with Tethered Inhibitors as a Diagnostic and Therapeutic Strategy for cancer and infectious diseases with Dr. Timothy Haystead.
Travis Hills of MN is Making Clean Water Accessible to All Through High Flux ...Travis Hills MN
By harnessing the power of High Flux Vacuum Membrane Distillation, Travis Hills from MN envisions a future where clean and safe drinking water is accessible to all, regardless of geographical location or economic status.
Immersive Learning That Works: Research Grounding and Paths ForwardLeonel Morgado
We will metaverse into the essence of immersive learning, into its three dimensions and conceptual models. This approach encompasses elements from teaching methodologies to social involvement, through organizational concerns and technologies. Challenging the perception of learning as knowledge transfer, we introduce a 'Uses, Practices & Strategies' model operationalized by the 'Immersive Learning Brain' and ‘Immersion Cube’ frameworks. This approach offers a comprehensive guide through the intricacies of immersive educational experiences and spotlighting research frontiers, along the immersion dimensions of system, narrative, and agency. Our discourse extends to stakeholders beyond the academic sphere, addressing the interests of technologists, instructional designers, and policymakers. We span various contexts, from formal education to organizational transformation to the new horizon of an AI-pervasive society. This keynote aims to unite the iLRN community in a collaborative journey towards a future where immersive learning research and practice coalesce, paving the way for innovative educational research and practice landscapes.
3. common methods in Drosophila to insert DNA into endogenous genes:
1. Transposable DNA elements: insert randomly in the genome
2. Homology-directed repair (HDR): insert DNA into a precise genomic location
-Plasmid used as donor DNA for HDR- Carry large DNA insert (# 10 kb) and genes homology arms
-Design and construction of plasmid donors for each gene can be laborious
-Cloning-free alternative strategy -synthesized donors:
A. Short ssDNA: > 2 kb
B. Long ssDNAs: < 2 kb
simpler and more scalable alternatives to knock-in large DNA elements into the genome
3. Homology-independent insertion
Background
4. Homology-independent insertion: CRISPaint: CRISPR assisted insertion tagging
-large DNA can be inserted without homology arms
-simultaneous cutting of a circular donor plasmid and a genomic site by a nuclease
-Integration of linearized insert DNA into the genomic cut site by nonhomologous end joining (NHEJ)
Homology independent insertion is less precise than HDR
o Donor DNA can insert in two directions
o Insertion/deletion mutations (indels) at the integration site can affect the insert translation frame
o Entire plasmid can integrate and
o Inserts can form concatemers
-Can be use: C-terminal protein tagging or gene disruption
This method has not been utilized in Drosophila
Background
5. Introduce components into Cas9-expressing cells:
(1) sgRNA targeting a genomic locus
(2) Donor plasmid containing an insert sequence
(3) Frame-selector sgRNA targeting the donor plasmid
CRISPaint system
6. knock-in verification by PCR and sequencing
34–50% of sense orientation insertions were in-frame with the
target gene
knock-in efficiency by FACs and confocal microscopy
mNeonGreen+ cells ranged from 0.19 to 2.4%
mNeonGreen localized to the expected subcellular compartments
significant number of transfected S2R+ cells received in-frame insertion of mNeonGreen at their C-terminus using the CRISPaint homology-
independent insertion method
7. Schematic of puromycin selection of mNeonGreen-expressing cells
Analysis of knock-in frequency of puromycin selected cells using FACS and confocal microscopy
31.7–89.1% of cells expressed mNeonGreen and exhibited correct subcellular localization
8. clonal cell lines displayed an
unusual localization pattern
Identified an unusual
mutation in clone
Analysis of S2R+ mNeonGreen-expressing single-cell cloned lines
9. To identify transgenic flies using a visible body marker that was not dependent on target gene expression
To target insertions to 59 coding sequences to create loss-of-function alleles by premature protein truncation
To test if insertion of a reporter could capture the expression of the target gene
New universal donor plasmid
Germ line knock-ins using homology-independent insertion
10. PCR and sequencing to confirm the insertion sites in our RFP+ lines
Insert orientation and frame of 20 RFP+ fly lines.
all 20 lines contained genomic sequence indels at the insertion site AND predominantly longer than indels in cultured cells
11. insertion lines for loss-of-function phenotypes
homozygous insertions in hh and wg
caused a “lawn of denticles”
phenotype in embryos
with heterozygous insertions in Mhc
were flightless
An insertion in myo1a (also known
asMyo31DF)was viable and flies exhibited
genital rotation phenotypes observed in
previously reported loss-offunction alleles
pCRISPaint-T2A-Gal4-3xP3-RFP universal donor plasmid inserts into target loci (59 coding sequence ) in fly germ line and
can be used to generate loss-of-function fly lines.
simplified universal donor plasmids
12. Determined if RFP+ lines expressed Gal4 from the target gene?
T2A-Gal4 reporter gene in pCRISPaint-T2A-Gal4-3xP3-RFP is promoter less
Sense orientation insertion and in-frame with the target gene should express Gal4
Approach:
20 RFP+ lines cross with UAS-GFP line and GFP fluorescence progeny screening
Gal4- expressing lines have T2A-Gal4 inserted in sense orientation, but that in-frame insertion with target-gene coding seq. is not necessarily a requirement for Gal4 expression
Knock-ins express Gal4 under the control of the target gene
13. -not been well studied
-did not know if ebony-T2A-Gal4 pFP545 #2 (“ebony-Gal4 CRISPaint”) was an accurate reporter
Approach:
Generated a precise in-frame HDR insertion in ebony (“ebony-Gal4 HDR”) using the same insert sequence (T2A-
Gal4-3xP3-RFP) and target-gene sgRNA (pFP545)
knock-in validated by PCR, homozygous flies were viable and had dark cuticle pigment
ebony expression: comparison study
14. CRISPaint and HDR knock-in alleles cross with UAS-GFP
Insertion is a concatemer
Gal4-expressing CRISPaint insertions can capture the endogenous expression pattern of the target gene
ebony expression: comparison study
15.
16. Advantage:
o Homology-independent insertion can be used as an alternative to HDR
o No donor design and construction
o knock-in lines are simple and fast to obtain
o Useful for C-terminal protein tagging in cultured cells and gene knockout by insertion in vivo
Limitations:
o Entire pCRISPaint donor plasmid integrates into a genomic target site
o Cannot be used to replace genes, make amino acid changes, or tag proteins at their N-termini
o Concatemerization of the insertion
Summary
Insertion of DNA into the animal genome is a powerful method to study gene function. This approach is multipurpose and can be used, for example, to alter gene function, assay gene expression, visualize protein localization, and purify endogenous proteins (Auer and Del Bene 2014; Singh et al. 2015).
Furthermore, the ability to insert large DNA elements such as promoters, protein-coding sequences, or entire genes into the genome offers researchers endless options for genome modification. Drosophila melanogaster is an excellent animal model with which to analyze gene function because of its many genetic tools, fast generation time, and in vivo analysis (Venken et al. 2016; Korona et al. 2017; Bier et al. 2018).
Two commonly used methods in Drosophila to insert DNA into endogenous genes are transposable DNA elements and homology-directed repair (HDR).
Transposable elements insert randomly in the genome (Bellen et al. 2011) and thus cannot be used to target a user-specified gene.
In contrast, HDR is used to insert DNA into a precise genomic location by homologous recombination (Bier et al. 2018).
Circular plasmids are commonly used as donor DNA for HDR because they can carry a large DNA insert (# 10 kb) and homology arms corresponding to the target locus are added by molecular cloning.
However, the design and construction of plasmid donors for each gene can be laborious and prone to troubleshooting.
As a cloning-free alternative, synthesized single stranded DNA (ssDNA) with short homology arms (50–100 bp each) (Bier et al. 2018) or long ssDNAs of#2 kb (Quadros et al. 2017; Kanca et al. 2019) can be used as donors.
However, ssDNA donors are limited to small insertions, and, like plasmid donors, must be designed and generated for each gene that is targeted by HDR. The burden of generating unique donor DNAs for HDR makes this method inefficient for targeting many genes in parallel, such as hits from a genetic or proteomic screen, or the same gene in divergent species.
Therefore, there is a need for simpler and more scalable alternatives to knock-in large DNA elements into the Drosophila genome.
Large DNA elements can also be inserted in target genes without homology arms, known as homology-independent insertion (Cristea et al. 2013; Maresca et al. 2013; Auer et al. 2014; Katic et al. 2015; Lackner et al. 2015; Schmid-Burgk et al. 2016; Suzuki et al. 2016; Katoh et al. 2017; Kumagai et al. 2017; Zhang et al. 2018; Gao et al. 2019).
In this method, simultaneous cutting of a circular donor plasmid and a genomic target site by a nuclease results in integration of linearized insert DNA into the genomic cut site by nonhomologous end joining (NHEJ).
Such donor plasmids are universal because they lack gene-specific homology arms, allowing insert sequences (e.g., GFP) to be targeted to any genomic location.
Despite this advantage, homology independent insertion is less precise than HDR. For example, donor DNA can insert in two directions, insertion/deletion mutations (indels) at the integration site can affect the insert translation frame, the entire plasmid can integrate, and inserts can form concatemers.
Nevertheless, for some targeting strategies such as C-terminal protein tagging or gene disruption, homology-independent insertion has been shown to be a fast, simple, and effective alternative to HDR in human cell lines (Cristea et al. 2013; Maresca et al. 2013; Lackner et al. 2015; Schmid-Burgk et al. 2016; Katoh et al. 2017; Zhang et al. 2018), mouse somatic cells (Suzuki et al. 2016; Gao et al. 2019), zebrafish (Auer et al. 2014), Caenorhabditis elegans (Katic et al. 2015), and Daphnia (Kumagai et al. 2017).
However, this method has not yet been utilized in Drosophila.
Here, we use the CRISPaint [clustered regularly interspaced short palindromic repeat (CRISPR)-assisted insertion tagging] strategy to show that homology-independent insertion functions effectively in Drosophila.
First, we inserted a mNeonGreen universal donor plasmid into four target genes in S2R1 cells, and used puromycin resistance (PuroR) to efficiently select for cell lines with fluorescently tagged endogenous proteins.
Second, we inserted a T2A-Gal4 3xP3- RFP (red fluorescent protein) universal donor plasmid into the fly germ line and isolated knock-in lines for seven genes by simple fluorescent screening.
By targeting insertions to 59 coding sequences, we demonstrate that this is an effective method to disrupt gene function and generate loss-of-function fly strains.
Furthermore, by screening insertions for Gal4 expression, we identified four that are in vivo reporters of their target gene.
To test if homology-independent insertion works in Drosophila, we implemented a strategy known as CRISPaint (Schmid-Burgk et al. 2016).
This system is used to insert sequence encoding a protein tag or reporter gene into the coding sequence of an endogenous gene. Although it was originally developed for mammalian cell culture, CRISPaint has several advantages for use in Drosophila.
First, this system uses CRISPR/Cas9 to induce double-strand breaks, which is known to function efficiently in cultured Drosophila cells (Bottcher et al. 2014; Viswanatha et al. 2018) and the germ line (Gratz et al. 2013; Kondo and Ueda 2013; Ren et al. 2013; Yu et al. 2013; Bassett et al. 2014).
Second, its use of a modular frame-selector system makes it simple to obtain insertions that are translated with the target gene.
Third, a collection of existing CRISPaint donor plasmids (Schmid-Burgk et al. 2016) containing common tags (e.g., GFP, RFP, and luciferase) are seemingly compatible for expression in Drosophila.
The CRISPaint system works by introducing three components into Cas9-expressing cells:
an sgRNA targeting a genomic locus,
a donor plasmid containing an insert sequence, and
a frame-selector sgRNA targeting the donor plasmid (Figure 1A).
This causes cleavage of both the genomic locus and the donor plasmid, leading to the integration of the entire linearized donor plasmid into the genomic cut site by NHEJ.
This insertion site destroys both sgRNA target sites and will no longer be cut. While indels can occur at the insertion site due to error-prone NHEJ, a remarkably high percentage of insertions in human cells are seamless (48–86%) (Schmid-Burgk et al. 2016).
Therefore, users have some control over their insertion frame by using one of three frame selector sgRNAs. Importantly, these frame-selector sgRNAs are predicted not to target the Drosophila genome.
Homology-independent insertion functions efficiently in Drosophila S2R+ cells to tag endogenous proteins
To test the CRISPaint method in Drosophila, we set out to replicate the findings of Schmid-Burgk et al. (2016) in cultured S2R+ cells by tagging endogenous proteins at their C-termini.
To accomplish this, we generated plasmids expressing frame selector sgRNAs (frame 0, 1, or 2) under the control of Drosophila U6 sequences (Port et al. 2015) (Figure 1A).
In addition, we generated plasmids expressing sgRNAs that target the 39 coding sequences of Drosophila Actin 5C Actin5c, His2Av, aTub84B, and Lamin because these genes are expressed in S2R+ cells (Hu et al. 2017) and encode proteins with known subcellular localizations (actin filaments, chromatin, microtubules, and the nuclear envelope, respectively).
For donor plasmid, we used pCRISPaint-mNeonGreen-T2A-PuroR Schmid-Burgk et al. 2016), which contains a frame-selector sgRNA target site upstream of coding sequence for the fluorescent mNeonGreen protein and PuroR protein linked by a cleavable T2A peptide sequence.
Only integration of the donor plasmid in-frame with the target coding sequence should result in the translation of mNeonGreen-T2A-PuroR (Figure 1A).
We transfected Cas9-expressing S2R+ cells (Viswanatha et al. 2018) with a mix of three plasmids:
pCRISPaint-mNeonGreen-T2A-PuroR donor,
target-gene sgRNA, and
the appropriate frame-selector sgRNA (Figure 1A and Table S1).
As an initial method to detect knock-in events, we used PCR to amplify the predicted insertion sites from transfected cells. Using primers that are specific to the target gene and mNeonGreen sequence, we successfully amplified sense orientation gene-mNeonGreen DNA fragments for all four genes (Figure 1B).
Furthermore, next-generation sequencing of these amplified fragments revealed that 34–50% of sense orientation insertions were in-frame with the target gene (Figure 1B, and Figure S1 and Table S1); 7–27% of sense orientation insertions were seamless, which is slightly lower than previously observed (Schmid-Burgk et al. 2016).
Next, we quantified in-frame knock-in frequency by measuring mNeonGreen fluorescence in transfected S2R+ cells. Flow cytometry-based cell counting of transfected cells revealed that the numbers of mNeonGreen+ cells ranged from 0.19 to 2.4% (Figure 1C and Table S1), in agreement with human cultured cells (Schmid-Burgk et al. 2016).
These results were confirmed by confocal analysis of transfected cells, which showed mNeonGreen fluorescence in a small subset of cells (Figure 1C); 3.2% (Act5c) and 2.4% (His2Av) of transfected cells expressed mNeonGreen (Figure 1C and Table S1), which roughly agreed with flow cytometry cell counting.
Finally, mNeonGreen localized to the expected subcellular compartments, most obviously observed by His2Av-mNeonGreen and Lam-mNeonGreen colocalization with the nucleus, and Act5C mNeonGreen and aTub84BmNeonGreen exclusion from the nucleus (Figure 1C). These results suggest that a significant number of transfected S2R+ cells received in-frame insertion of mNeonGreen at their C-terminus using the CRISPaint homology-independent insertion method.
For knock-in cells to be useful in experiments, it is important to derive cultures where most cells, if not all, carry the insertion. Therefore, we enriched for in-frame insertion events using puromycin selection (Figure 1D).
After a 2-week incubation of transfected S2R+ cells with puromycin, flow cytometry and confocal analysis revealed that 31.7–89.1% of cells expressed mNeonGreen and exhibited correct subcellular localization (Figure 1E and Table S1).
For aTub84B, cell counting by flow cytometry greatly underestimated the number of mNeonGreen+ cells counted by confocal analysis, likely because mNeonGreen expression level was so low. These results demonstrate that puromycin selection is a fast and efficient method of selecting for mNeonGreen expressing knock in cells.
A subset of cells in puromycin-selected cultures had no mNeonGreen expression or unexpected localization (Figure 1E).
Since each culture is composed of different cells with independent insertion events, we used FACS to derive single cell cloned lines expressing mNeonGreen for further characterization (Figure 2A).
At least 14 single-cell cloned lines were isolated for each target gene and imaged by confocal microscopy. Within a given clonal culture, each cell exhibited the same mNeonGreen localization (Figure 2B), confirming our single-cell cloning approach and demonstrating that the insertion was genetically stable over many cell divisions.
Importantly, while many clones exhibited the predicted mNeonGreen localization, a subset of the clonal cell lines displayed an unusual localization pattern (Figure 2B). For example, 3/21 Act5c mNeonGreen clones had localization in prominent rod structures and 12/14 Lamin-mNeonGreen clones had asymmetric localization in the nuclear envelope (Figure 2B). In addition, some clones had diffuse mNeonGreen localization in the cytoplasm and nucleus (Figure 2B).
To better characterize the insertions in single-cell cloned lines, we further analyzed three clones per gene (12 total), selecting different classes when possible (correct localization, unusual localization, and diffuse localization) (Figure 2C and Table S2).
Using PCR amplification of the predicted insertion site (Figure 1A and Figure 2D) and sequencing of amplified fragments (Figure 2E and Table S2), we determined that all clones with correct or unusual mNeonGreen localization contained an in-frame insertion of mNeonGreen with the target gene.
In contrast, we were unable to amplify DNA fragments from the expected insertion site in clones with diffuse mNeonGreen localization (Figure 2D). Western blotting of cell lysates confirmed that only clones with in-frame mNeonGreen insertion express fusion proteins that match the predicted molecular weights (Figure 2F). All together, these results suggest that clones with correct mNeonGreen localization are likely to contain an in-frame insert in the correct target gene.
S2R+ cells are polyploid (Lee et al. 2014), and clones expressing mNeonGreen could bear one or more insertions. Furthermore, indels induced at the noninsertion locus could disrupt protein function.
To explore these possibilities, we amplified the noninsertion locus in our single-cell cloned lines and used Sanger and next-generation sequencing to analyze the DNA fragments (Figure 2D and Table S2).
For each gene, we could find indels occurring at the noninsertion sgRNA cut site. For example, we could distinguish four distinct alleles in clone B11: a 3-bp deletion, a 2-bp deletion, a 1-bp deletion, and a 27-bp deletion.
In addition, we identified an unusual mutation in clone C6, where a 1482-bp DNA fragment inserted at the sgRNA cut site, which corresponds to a region from aTub84D. We assume that this large insertion was caused by homologous recombination, since aTub84D and aTub84B share 92% genomic sequence identity (FlyBase, http://flybase.org/).
For Act5c-mNeonGreen clones A5 and A19, numerous indel sequences were found, suggesting that this region has an abnormal number of gene copies. We were unable to amplify a DNA fragment of the non-insertion allele from Lam-mNeonGreen D9, despite follow-up PCRs using primers that bind genomic sequences further away from the insertion site (data not shown).
Loss-of-function knock-in fly lines by homology independent insertion in the germ line:
We next explored whether homology-independent insertion could function in the Drosophila germ line for the purpose of generating knock-in fly strains. As opposed to antibiotic selection in cultured cells:
We wanted to identify transgenic flies using a visible body marker that was not dependent on target gene expression.
In addition, we wanted to target insertions to 59 coding sequences to create loss-of-function alleles by premature protein truncation.
Finally, we wanted to test if insertion of a reporter could capture the expression of the target gene.
To accomplish these goals, we constructed a new universal donor plasmid called pCRISPaint-T2A-Gal4-3xP3-RFP (Figure 3A). This donor contains
a frame-selector sgRNA target site upstream of T2A-Gal4, which encodes a self-cleaving form of the transcription factor (Diao and White 2012).
This donor plasmid also contains the transgenesis marker 3xP3- RFP, which expresses red fluorescence in larval tissues and the adult eye (Berghammer et al. 1999) (Figure 3A).
To test if homology-independent insertion functions in the germ line and determine its approximate efficiency, we targeted 11 genes using pCRISPaint-T2A-Gal4-3xP3-RFP (Table S3).
These genes were selected based on their known loss-of function phenotypes, expression patterns, and availability of sgRNA plasmids from the TRiP (https://fgr.hms.harvard.edu/).
Plasmid mixes of donor, frame-selector, and target-gene sgRNA were injected into nos-Cas9 embryos, and the resulting G0 progeny were crossed to yw.
G1 progeny were screened for RFP fluorescence in adult eyes, and each RFP+ founder fly was crossed to balancer flies to establish a stable stock (Figure 3B).
Figure 3C and Table S3 show the integration efficiency results for each gene, and Table S4 has information on 20 RFP+ lines, each derived from a different G0 founder.
For injections that produced RFP+ animals, the frequency of G0 crosses yielding RFP+ G1 progeny ranged from 5 to 21% (Figure 3C and Table S3).
For example, when targeting ebony with sgRNA pFP545, three out of 16 G0 crosses produced $ 1 RFP+ G1 flies. In 1 month following embryo injection, we obtained balanced RFP+ lines for 7 out of 11 genes targeted (64%) (Figure 3C and Table S3).
Next, we used PCR and sequencing to confirm the insertion sites in our RFP+ lines. For each target site, we used two primer pairs to detect the presence of an on-target insertion as well as its orientation (Figure S2).
Gel images of PCR-amplified DNA showed that all 20 of our RFP+ lines contained an insertion in the correct target site (Figure S2 and Table S4), where 13 insertions were in the sense orientation and 7 were antisense (Figure 3D). Sequence analysis of PCR fragments confirmed that the insertions were present at the target site (Figure S3 and Table S4).
Unexpectedly, all 20 lines contained genomic sequence indels at the insertion site (Figure S3), unlike the frequent seamless insertions observed in cultured cells.
Germ line indels were also predominantly longer than indels in cultured cells. In particular, a remarkably long 1896-bp genomic deletion was found at the hh insertion site. Regardless, these results demonstrate that all 20 independently derived RFP+ lines contained pCRISPaint-T2A-Gal4-3xP3-RFP at the target site.
Next, we analyzed insertion lines for loss-of-function phenotypes.
Flies with insertions in wg, Mhc, hh, and esg were homozygous lethal (Table S4), which is consistent with characterized mutations in these genes (FlyBase). Similarly, complementation tests revealed that insertions in wg, Mhc, hh, and esg were lethal in trans with loss-of-function alleles or genomic deletions spanning the target gene (Table S4).
In addition, homozygous insertions in hh and wg caused a “lawn of denticles” phenotype in embryos (Bejsovec and Martinez Arias 1991) (Figure 3F) and flies with heterozygous insertions in Mhc were flightless (Mogami et al. 1986) (data not shown), all reminiscent of previously characterized mutants.
Four insertions in ebony produced flies with dark cuticle pigment when homozygous (Figure 3E and Table S4) or in trans with ebony1 (data not shown).
In one case (ebony pFP545#2), the insertion was homozygous lethal but was viable over ebony1, and transhet flies exhibited dark cuticle pigment.
An insertion in myo1a (also known asMyo31DF) was viable and flies exhibited genital rotation phenotypes observed in previously reported loss-of function alleles (Spéder et al. 2006) (Figure 3G).
An insertion in FK506-bp2 was homozygous viable, though this gene has not been well characterized in Drosophila.
In all, these results indicate that insertion of pCRISPaint-T2A-Gal4-3xP3-RFP into 59 coding sequence can disrupt gene function.
An important consideration when using genome editing is off-target effects. For example, in addition to on-target insertions, our RFP+ fly lines could contain off-target insertions or other mutations that disrupt non target genes.
We noticed that RFP fluorescence always co-segregated with the target chromosome when balancing insertions (data not shown), suggesting that multiple insertions may be uncommon.
Furthermore, we did not detect evidence of off-target insertions by splinkerette PCR (Potter and Luo 2010), which largely reconfirmed the on-target sites (Table S4).
However, this analysis was problematic because some sequence traces aligned to the donor plasmid or to genomic sequence on the opposite expected side of the target site, suggesting that insertions could be concatemers.
Others have observed concatemers when performing NHEJ knock-ins (Auer et al. 2014; Kumagai et al. 2017), and we found that seven of our RFP+ insertions were head-to-tail concatemers as determined by PCR (Figure S4). We could rescue the lethality of our esg insertion using a duplication chromosome (stock # BL6230), suggesting that there were no other second-site lethal mutations on this chromosome. Finally, one of five ebony insertions (ebony pFP545 #2) was homozygous lethal, suggesting it contains a second-site lethal mutation.
We did not obtain insertions when targeting ap, aTub84B, btl, or Desat1. Therefore, we investigated whether the sgRNAs targeting these genes were functional. Four sgRNAs used for germ line knock-ins had an acceptable efficiency score of > 5, with the exception being the sgRNA targeting btl (Table S5).
Performing a T7 endonuclease assay from transfected cells revealed that sgRNAs targeting ap, aTub84B, and btl can cut at the target site, whereas the results with Desat1 were inconclusive (Figure S5A). As an alternative functional test, we used PCR to detect knock-in events in S2R+ cells transfected with the pCRISPaint-T2AGal4- 3xP3-RFP donor plasmid.
This showed that sgRNAs targeting ap, aTub84B, btl, and Desat1 can lead to successful knock-in of pCRISPaint-T2A-Gal4-3xP3-RFP and suggests that the sgRNAs are functional (Figure S5B).
Finally, we sequenced the sgRNA target sites in the nos-Cas9 fly strains and found a SNP in the btl sgRNA-binding site (data not shown), whereas all 10 remaining sgRNAs had no SNPs in the target site.
In summary, we conclude that the sgRNAs targeting ap, aTub84B, btl, and Desat1 are able to induce cleavage at their target site in S2R+ cells, but that the sgRNA targeting btl may not function in the germ line using our nos-Cas9 strains.
Collectively, our results demonstrate that the pCRISPaint-T2A-Gal4-3xP3-RFP universal donor plasmid inserts into target loci in the fly germ line and can be used to generate loss-of-function fly lines.
Therefore, we generated two simplified universal donor plasmids that were more tailored to this purpose: pCRISPaint-3xP3-RFP and pCRISPaint-3xP3- GFP (Figure 3H). These donor plasmids contain green or red fluorescent markers, and a useful multiple cloning site for adding additional insert sequence.
Knock-ins that express Gal4 under the control of the target gene:
We next determined if any of our 20 RFP+ lines expressed Gal4 from the target gene. Since the T2A-Gal4 reporter gene in pCRISPaint-T2A-Gal4-3xP3-RFP is promoter less, we reasoned that only insertions in the sense orientation and in-frame with the target gene should express Gal4.
We took an unbiased approach by crossing all 20 RFP+ lines to UAS-GFP and screening progeny for GFP fluorescence throughout development. From this effort, we identified six Gal4-
expressing lines (Figure 4A, and Table S4).
wg-T2A-Gal4 (#1 and 4), Mhc-T2A-Gal4 (#1 and 2), and Myo1a-T2AGal4 #1 insertions were expressed in the imaginal disc, larval muscle, and larval gut (Figure 4B and Table S4), respectively, which matched the known expression patterns for these genes. wg-T2A-Gal4 #1 and #4 insertions were expressed in a distinctive Wg pattern in the wing disc pouch (Figure 4C). ebony-T2A-Gal4 pFP545 #2 was expressed in the larval brain and throughout the pupal body (Figure 4D), consistent with a previous study (Hovemann et al. 1998). Interestingly, it was also expressed in the larval trachea, with particularly strong expression in the anterior and posterior spiracles. Indeed, classical ebony mutations are known to cause dark pigment in larval spiracles (Brehme 1941).
Next, we compared the Gal4 expression results with our sequence analysis of the insertion sites. As expected, all lines that expressed Gal4 had insertions that were in the sense orientation (Figures S2 and S3, and Table S4).
For example, ebony-T2A-Gal4 pFP545 #2 contains a 15-bp genomic deletion that is predicted to keep T2A-Gal4 in-frame with ebony coding sequence. Similarly, wg-T2A-Gal4 #1 contains an in-frame 45-bp deletion and 21-bp insertion. Remarkably, wg-T2AGal4 #4 contains a frameshift indel (Figure S3), yet still expresses Gal4 in the Wg pattern, albeit at significantly lower levels than wg T2A-Gal4 #1 (Figure 4C). In addition, Mhc-T2A-Gal4 lines #1 and #2, andMyo1a-T2A-Gal4 #1 each have indels that put T2A-Gal4 out-of-frame with the target-gene coding sequence.
These findings confirm that our Gal4- expressing lines have T2A-Gal4 inserted in the sense orientation, but that in-frame insertion with the target-gene coding sequence is not necessarily a requirement for Gal4 expression. Artifacts due to homology-independent insertion, such as indels at the insertion site, could conceivably interfere with Gal4 expression.
For example, ebony expression has not been well studied, so we did not know if ebony-T2A-Gal4 pFP545 #2 (“ebony-Gal4 CRISPaint”) was an accurate reporter. To address this issue, we generated a precise in-frame HDR insertion in ebony (“ebony-Gal4 HDR”) using the same insert sequence (T2A-Gal4-3xP3-RFP) and target-gene sgRNA (pFP545).
ebony-Gal4 HDR knock-in fly lines were validated by PCR (Figure S6), and ebony-Gal4 HDR homozygous flies were viable and had dark cuticle pigment (data not shown), suggesting on-target knock-in.
By crossing CRISPaint and HDR knock-in alleles with UAS-GFP, we found that their expression patterns were similar at larval, pupal, and adult stages (Figure 4, D and E). However, ebony Gal4 CRISPaint had higher levels of RFP fluorescence, and expressed Gal4 in the larval anal pad and gut, which is coincident with expression of 3xP3-RFP. Since this insertion is a concatemer (Figure S4 and Table S4), we speculated that multiple copies of 3xP3-RFP lead to increased RFP fluorescence and ectopic expression of Gal4. Unfortunately, we could not test this because our efforts to remove 3xP3-RFP using Cre/loxP excision were unsuccessful; progeny expressing Cre and ebony-Gal4 CRISPaint were apparently lethal, whereas we easily generated RFP-free derivatives of ebony Gal4 HDR using the same crossing scheme.
In contrast, Mhc-T2A-Gal4 lines #1 and #2, and Myo1a-T2A-Gal4 #1 do not express in the anal pad, and gut and anal pad expression in wg-T2A-Gal4 #1 likely corresponds to normal wg expression in these tissues (Takashima and Murakami 2001) (Figure 4B).
In conclusion, these results suggest that Gal4-expressing CRISPaint insertions can capture the endogenous expression pattern of the target gene, albeit with caveats that we demonstrated (also see Discussion).
To facilitate the insertion of other sequences into the germ line to generate expression reporters, we created 10 additional universal donor plasmids (Figure 4F). These include T2Acontaining donors with sequence encoding the alternative binary reporters LexGAD, QF2, and split-Gal4, as well as Cas9 nuclease, FLP recombinase, Gal80 repression protein, NanoLuc luminescence reporter, and superfolder GFP. In addition, we generated pCRISPaint-sfGFP-3xP3-RFP, which can be used to insert into 39 coding sequence, generating a C-terminal GFP fusion protein.
Finally, we created a single plasmid expressing all three frame-selector sgRNAs (pCFD5-frame-selectors_0,1,2). Since indels at the insertion site in the germ line effectively randomize the coding frame, we reasoned that simultaneous expression of all three sgRNAs would maximize cutting and linearization of a CRISPaint universal donor plasmid.
In summary, we demonstrated that homology-independent insertion can be used as an alternative to HDR in Drosophila, enabling researchers to rapidly obtain knock-ins without donor design and construction. The most practical application of this approach is to perform C-terminal protein tagging in cultured cells and gene knockout by insertion in vivo. While we obtained in vivo T2A-Gal4 gene-tagged insertions, it is low efficiency and thus less appealing compared to HDR. However, the techniques required for screening insertions for T2A-Gal4 expression are less specialized than those for constructing donor plasmids, making this trade off potentially attractive for those with less molecular biology expertise or who previously failed using HDR. Finally, our in vivo donor plasmids are immediately useable in other arthropod species because of the 3xP3-fluorescent marker (Berghammer et al. 1999), a testament to the modularity of this knock-in system, and the benefit of a community of researchers creating and sharing universal donor plasmids.
Discussion
Inserting large DNA elements into the genome by HDR requires a great deal of expertise and labor for the design, and construction, of donor plasmids. Some groups have developed strategies to improve the efficiency and scale at which homology arms are cloned into donor plasmids (Housden et al. 2014; Gratz et al. 2015; Kanca et al. 2019), but the root problem still remains. In this study, we showed that homology-independent insertion can be used in Drosophila as an alternative to HDR for certain genetargeting strategies in cultured cells and in vivo. With no donor design and construction, knock-in lines are simple and fast to obtain (see Table 1). To performhomology-independent insertion in Drosophila, we adapted the mammalian CRISPaint system (Schmid-Burgk et al. 2016) because of its user-friendly design. CRISPaint donor plasmids are universal because they lack homology arms, and publicly available collections enable researchers to “mix and match” insert sequences and target genes. Indeed, we showed that pCRISPaint-mNeonGreen-T2A-PuroR, originally used in human cells, functions in Drosophila S2R+ cells (Figure 1). To linearize donor plasmids in Drosophila in three coding frames, we generated plasmids expressing the three CRISPaint frame-selector sgRNAs under the Drosophila U6 promoter. Similarly, we also generated a plasmid to express all three sgRNAs simultaneously for maximum cutting efficiency. Therefore, to perform a knock-in experiment, only an sgRNA that targets a gene of interest is needed, which is simple to produce by molecular cloning or ordering. In fact, all target gene sgRNA plasmids used in this study were obtained from the TRiP facility where an ever-growing number of sgRNAs are being generated.
Unlike HDR, which can seamlessly insert any DNA into a target genomic location, homology-independent insertion is restricted to specific targeting scenarios. For example, since the entire pCRISPaint donor plasmid integrates into a genomic target site, it cannot be used to replace genes, make amino acid changes, or tag proteins at their N-termini. In addition, potential concatemerization of the insertion (Auer et al. 2014; Kumagai et al. 2017) prevents its use for strategies where a single copy of the insertion is required, such as artificial exon traps that exploit target gene splicing (Buszczak et al. 2007). Despite these limitations, homology-independent insertion was previously shown to be useful for generating loss-offunction alleles by premature truncation (Cristea et al. 2013; Auer et al. 2014; Katic et al. 2015; Katoh et al. 2017; Zhang et al. 2018) as well as C-terminal gene tagging (Lackner et al. 2015; Schmid-Burgk et al. 2016; Gao et al. 2019).